Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Innovation Alliance (TIA) is a healthcare joint venture formed through a partnership between The University of Kansas Health System and Ardent Health Services. The organization is designed to expand access to advanced clinical research and innovative medical treatments across community-based healthcare settings. By leveraging the academic expertise of The University of Kansas Health System and the operational scale of Ardent Health Services, TIA facilitates the delivery of clinical trials in areas such as oncology, cardiology, and neurology. The alliance aims to bridge the gap between academic medical centers and community hospitals, ensuring that patients in diverse geographic regions have access to the latest therapeutic breakthroughs. TIA operates as a clinical research network, providing the infrastructure necessary for pharmaceutical and biotech companies to conduct multi-site trials efficiently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Innovation Alliance.